Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $13.57
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 13, 26 |
| Truist Securities |
| maintain |
| Hold |
| Hold |
| Aug 5, 26 | Needham | maintain | Hold | Hold |
| Jul 17, 26 | Wells Fargo | maintain | Overweight | Overweight |
| May 6, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| May 6, 26 | TD Cowen | maintain | Hold | Hold |
| Feb 13, 26 | Stifel | maintain | Hold | Hold |
| Dec 18, 25 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Nov 5, 25 | Wells Fargo | maintain | Overweight | Overweight |
| Nov 5, 25 | Stifel | maintain | Hold | Hold |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 56.44 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 83.40 | Oscillator | Sell |
| Williams %R (14) | -29.20 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.17 (Hist 0.15) | Oscillator | Strong Buy |
| Average Directional Index (14) | 13.95 (+DI 24.3 / -DI 15.7) | Trend | Neutral |
| EMA 20 | 12.95 | MA | Strong Buy |
| SMA 20 | 12.82 | MA | Strong Buy |
| EMA 50 | 12.55 | MA | Strong Buy |
| SMA 50 | 12.76 | MA | Strong Buy |
| SMA 200 | 8.71 | MA | Strong Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | AMWL | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -2.8x | -2.7x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -5.3x | EPS est. -2.57 | Elevated |
| Price / Book | 1.0x | 0.7x | Elevated |
| Price / Sales | 1.1x | 2.2x | Discount |
| EV / EBITDA | -0.9x | -0.8x | In line |
| Return on equity | -33.3% | — | Weak |
| Gross margin | 48.4% | 42.4% | In line |
| Debt / Equity | 0.01 | 0.02 | Conservative |
| Piotroski / Altman Z | 2/9 | Z -6.89 | Distress |
Discounted cash flow model
Stock news · updated daily
BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health's use of SilverCloud® by Amwell® to deliver a fully funded digital mental health benefit in South Africa. The case study examines the three questions health plans ask of digital care: whether members will use it, whether it improves their health, and what it does to costs.
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
On September 30, 2026, American Well Corp (AMWL) shares rose 3.4% to $13.58, continuing a strong upward trend over the past month, where the stock has appreciat
American Well Corporation (AMWL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Valuation and Earnings This table compares American Well and
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -0.86 | -0.59 | Beat 31.4% | $52.05M |
| May 5, 2026 | -0.77 | -0.66 | Beat 14.3% | $54.88M |
| Feb 12, 2026 | -1.59 | -1.43 | Beat 10.1% | $55.31M |
| Nov 4, 2025 | -1.46 | -1.74 | Miss -19.4% | $56.29M |
| Aug 5, 2025 | -1.84 | -1.24 | Beat 32.6% | $70.90M |
| May 1, 2025 | -3.09 | -1.73 | Beat 44.0% | $66.83M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 5, 2026 | 2026-10-05 17:32:03 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:28:45 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:25:20 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:23:28 | View |
| 4 | Sep 3, 2026 | 2026-09-03 17:11:53 | View |
| 4 | Sep 3, 2026 | 2026-09-03 17:09:03 | View |
| 4 | Sep 3, 2026 | 2026-09-03 17:06:41 | View |
| 144 | Sep 1, 2026 | 2026-09-01 17:18:44 | View |
| 144 | Sep 1, 2026 | 2026-09-01 17:15:23 | View |
| SC 13G/A | Aug 13, 2026 | 2026-08-13 16:15:09 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Gotlib Phyllis | officer: President, International | S-Sale | 6,677 @ $13.00 | $86.80K |
| Oct 1, 26 | Hirschhorn Mark | officer: Chief Financial Officer | S-Sale | 4,282 @ $13.00 | $55.67K |
| Oct 1, 26 | Zamansky Dmitry | officer: Chief Product & Tech. Officer | S-Sale | 8,442 @ $13.00 | $109.7K |
| Oct 1, 26 | Mcneice Paul Francis | officer: Chief Accounting Officer | S-Sale | 653 @ $13.00 | $8.49K |
| Sep 1, 26 | Hirschhorn Mark | officer: Chief Financial Officer | S-Sale | 10,751 @ $11.80 | $126.9K |
| Sep 1, 26 | Gotlib Phyllis | officer: President, International | S-Sale | 3,573 @ $11.80 | $42.16K |
| Sep 1, 26 | Mcneice Paul Francis | officer: Chief Accounting Officer | S-Sale | 112 @ $11.80 | $1.32K |
| Jul 1, 26 | Mcneice Paul Francis | officer: Chief Accounting Officer | S-Sale | 653 @ $9.33 | $6.09K |